Prevalence of Insomnia among Pancreatic Cancer Patients following Pancreaticoduodenectomy

Table 3

Prevalence of mild insomnia and moderate to severe insomnia in patients postpancreaticoduodenectomy.

Variable			ISI score 8–14 ()	ISI ()
Age,
Gender, (%)	Male		8 (66.7%)	5 (71.4%)
	Female		4 (33.3%)	2 (28.6%)
BMI,
Smoking, (%)			2 (16.7%)	3 (42.9%)
Alcohol consumption, (%)			2 (16.7%)	3 (42.9%)
Caffeine intake, (%)			5 (41.7%)	5 (71.4%)
Physical activity, (%)			8 (66.7%)	5 (71.4%)
Comorbidities, (%)	Diabetes		5 (41.7%)	3 (42.9%)
	COPD		0	0 (4.5%)
	CVD		6 (50.0%)	4 (57.1%)
	CKD		0	1 (14.3%)
Tumor characteristics, (%)	Grade	1	1 (8.3%)	1 (14.3%)
		2	7 (58.3%)	6 (85.7%)
		3	4 (33.3%)	0
		4	0	0
	T stage	1	0	2 (28.6%)
		2	9 (75.0%)	4 (57.1%)
		3	3 (25.0%)	1 (34.3%)
		4	0	0
	N stage	0	3 (25.0%)	2 (28.6%)
		1	5 (41.7%)	4 (57.1%)
		2	4 (33.3%)	1 (14.3%)
	M stage	0	11 (91.7%)	7 (100.0%)
		1	1 (8.3%)	0
Tumor size,
Treatment regimen, (%)	Adjuvant chemotherapy		6 (50.0%)	6 (85.7%)
	Neoadjuvant chemotherapy		0	1 (14.3%)
	Adjuvant radiotherapy		0	0
	Neoadjuvant radiotherapy		0	0
	No chemotherapy or radiotherapy		6 (50.0%)	0
All-cause mortality, (%)			1 (8.3%)	0

BMI: body mass index; COPD: chronic obstructive pulmonary disease; CVD: cardiovascular disease; CKD: chronic kidney disease; ISI: Insomnia Severity Index; PSQI: Pittsburgh Sleep Quality Index. Significance at ; significance at .